HF 2906 Minnesota 2025-2026 session
Psilocybin therapeutic use program established; protections for registered patients, designated cultivators, registered facilitators, and health care practitioners established; rulemaking authorized; civil actions authorized; fees established; advisory committee established; criminal penalties provided; and money appropriated.
Status
- Introduced
- Committee
- Floor vote
- Passed
- Enacted
Awaiting a floor vote — last recorded action April 22, 2026
Author added Rymer
Passage likelihood
95% Higher than most bills at this stage
This is an estimate, not a guarantee. It is computed from the signals listed below and nothing else. It does not account for leadership priorities, floor scheduling, or negotiations that are not in the public record.
What the estimate is based on
- Historical base rate About 20% of introduced state bills are enacted.
- Current stage Scheduled for or awaiting a floor vote.
- Cosponsors 9 cosponsors.
- Must-pass vehicle This is an appropriations or authorization bill that the chamber has historically acted on each session.
State-level impact
State-level impact data is not available for this bill. The source text does not contain a per-state funding formula or scored breakdown, so no figures are shown.
Official actions
- Author added Rymer
- Committee report, to adopt as amended and re-refer to Commerce Finance and Policy
- Authors added Repinski and Lee, X.
- Author added West as second author
- Author added Sencer-Mura
- Introduction and first reading, referred to Health Finance and Policy